Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance

@inproceedings{Lee2014ExpressionOH,
  title={Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance},
  author={Sung Hak Lee and Changyoung Yoo and Soyoung Im and J Jung and Hyun Joo Choi and Jinyoung Yoo},
  booktitle={International journal of medical sciences},
  year={2014}
}
BACKGROUND Histone deacetylase inhibitors are a new class of drugs used in treatment of malignant tumors. Diffuse large B-cell lymphoma (DLBCL) is the most common type of B-cell lymphoma, and it accounts for more than 40% of all B-cell lymphomas. In this study, we aimed to determine the expression patterns of histone deacetylases (HDACs) in DLBCL, to examine whether HDAC expression patterns differ among cases, and to assess whether these findings have clinical significance. MATERIALS AND… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
5 Citations
24 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Similar Papers

Loading similar papers…